Nymox Pharmaceutical (NYMXF) Cash from Financing Activities (2017 - 2024)
Nymox Pharmaceutical's Cash from Financing Activities was $1.74 million in FY2025, down 33.2% from $2.61 million in FY2024.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Cash from Financing Activities (2017 - 2024) Analysis & Trends
From FY2015 onward, Nymox Pharmaceutical has reported Cash from Financing Activities for 11 years.
- Cash from Financing Activities has now declined for five consecutive years, with a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Cash from Financing Activities in data going back to FY2015.
- Per Business Quant data, Cash from Financing Activities in earlier years was $2.61 million in FY2024 (-4.5%), $2.73 million in FY2023 (-52.8%), $5.78 million in FY2022 (-18.0%) and $7.05 million in FY2021 (-16.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Nymox Pharmaceutical | 5.76 Mn | 5.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 750,000.00 |
| Dec 31, 2023 | 891,000.00 |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 690,000.00 |
| Mar 31, 2023 | -61,000.00 |
| Dec 31, 2022 | -52,000.00 |
| Sep 30, 2022 | -60,000.00 |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | 4.05 Mn |
| Dec 31, 2021 | -59,000.00 |
| Sep 30, 2021 | -59,000.00 |
| Jun 30, 2021 | 7.22 Mn |
| Mar 31, 2021 | -60,000.00 |
| Dec 31, 2020 | -58,000.00 |
| Sep 30, 2020 | 8.62 Mn |
| Jun 30, 2020 | -71,000.00 |
| Mar 31, 2020 | -68,000.00 |
| Dec 31, 2019 | -89,000.00 |
| Sep 30, 2019 | -63,000.00 |
| Jun 30, 2019 | -65,000.00 |
API Access
Nymox Pharmaceutical Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();